For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. In 2019 Lilly created Loxo Oncology at Lilly, with the goal of rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating new medicines that unequivocally work in early clinical development and will matter to patients. To learn more about Lilly's commitment to people with cancer, please visit LillyOncology.com.
Brands: https://events.jspargo.com/ASCO21/CUSTOM/lillybanner.jpg
Show Specials
-
David Hyman, chief medical officer, Loxo Oncology at Lilly, shares our commitment to supporting the oncology community and our goal to continue discovering and developing the next generation of cancer therapies. #ASCO21.
To watch the full video, click here.
-
We're proud to participate in the American Society of Clinical Oncology's 2021 virtual meeting and look forward to sharing our advancements in #oncology. Anne White, president, Lilly Oncology, highlights Lilly's commitment to improving the lives of people living with cancer, and our collaborative approach to treatment. #ASCO21.
Watch the full video by clicking here.
Press Releases